Title | Type | SJR | H index | Total Docs. (2001) | Total Docs. (3years) | Total Refs. (2001) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2001) | %Female (2001) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
239 | Acta Biotechnologica | journal | 0.302 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
238 | Antiviral Chemistry and Chemotherapy, Supplement | journal | 12 | 17 | 0 | 1305 | 0 | 0 | 0.00 | 76.76 | 33.33 | ||
237 | Applied Mycology and Biotechnology | book series | 16 | 15 | 0 | 2663 | 0 | 0 | 0.00 | 177.53 | 25.00 | ||
236 | Biotechnology Techniques | journal | 0.315 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
235 | BMC Microbiology | journal | 137 | 34 | 0 | 1012 | 0 | 0 | 0.00 | 29.76 | 37.50 | ||
234 | Bulletin de l'Institut Pasteur | journal | 0.225 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
233 | CME Bulletin Sexually Transmitted Infections and HIV | journal | 0.102 Q4 | 1 | 9 | 14 | 86 | 0 | 11 | 0.00 | 9.56 | 33.33 | |
232 | Dengue Bulletin | journal | 27 | 22 | 0 | 187 | 0 | 0 | 0.00 | 8.50 | 30.19 | ||
231 | Epstein-Barr Virus Report | journal | 2 | 12 | 0 | 441 | 0 | 0 | 0.00 | 36.75 | 12.50 | ||
230 | Eurosurveillance | journal | 131 | 36 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 38.46 | ||
229 | FEMS Yeast Research | journal | 109 | 32 | 0 | 841 | 0 | 0 | 0.00 | 26.28 | 30.51 | ||
228 | Genetic Analysis - Biomolecular Engineering | journal | 0.790 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
227 | Immunology. Supplement | journal | 0.121 Q4 | 0 | 0 | 1 | 0 | 0 | 1 | 0.00 | 0.00 | 0.00 | |
226 | Immunotechnology | journal | 0.774 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
225 | Infection, Genetics and Evolution | journal | 112 | 19 | 0 | 708 | 0 | 0 | 0.00 | 37.26 | 22.64 | ||
224 | International Congress Series | book series | 43 | 359 | 0 | 4433 | 0 | 0 | 0.00 | 12.35 | 22.64 | ||
223 | International Journal of Immunopharmacology | journal | 0.325 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
222 | Journal of HIV Therapy | journal | 18 | 21 | 0 | 568 | 0 | 0 | 0.00 | 27.05 | 32.14 | ||
221 | Journal of International Peacekeeping | journal | 14 | 25 | 76 | 1264 | 0 | 64 | 0.00 | 50.56 | 25.00 | ||
220 | Journal of Molecular Microbiology and Biotechnology | journal | 1.198 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
219 | Medecine Tropicale | journal | 0.236 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
218 | Minerva Biotecnologica | journal | 0.120 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
217 | Molecular Marine Biology and Biotechnology | journal | 0.752 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
216 | Nature Reviews Immunology | journal | 467 | 42 | 0 | 2321 | 0 | 0 | 0.00 | 55.26 | 26.53 | ||
215 | NeuroImmune Biology | book series | 12 | 41 | 0 | 2062 | 0 | 0 | 0.00 | 50.29 | 31.51 | ||
214 | Papillomavirus Report | journal | 7 | 18 | 0 | 217 | 0 | 0 | 0.00 | 12.06 | 37.50 | ||
213 | Perspectives in Medical Virology | book series | 14 | 16 | 0 | 3227 | 0 | 0 | 0.00 | 201.69 | 30.43 | ||
212 | Progress in Industrial Microbiology | journal | 0.100 Q4 | 12 | 0 | 42 | 0 | 0 | 41 | 0.00 | 0.00 | 0.00 | |
211 | RBM - Revue Europeenne de Technologie Biomedicale | journal | 0.103 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
210 | Research in Immunology | journal | 0.538 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
209 | Research in Virology | journal | 0.441 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
208 | Quantitative Microbiology | journal | 0.102 Q4 | 9 | 0 | 13 | 0 | 1 | 13 | 0.08 | 0.00 | 0.00 | |
207 | BMC Immunology | journal | 1.540 Q1 | 73 | 11 | 1 | 410 | 2 | 1 | 2.00 | 37.27 | 17.07 | |
206 | Clinical and Applied Immunology Reviews | journal | 20 | 31 | 10 | 1255 | 2 | 8 | 0.20 | 40.48 | 27.69 | ||
205 | Inflamacion y Regulacion del Crecimiento Celular | journal | 0.102 Q4 | 1 | 0 | 9 | 0 | 2 | 9 | 0.00 | 0.00 | 0.00 | |
204 | International Journal of Thymology | journal | 0.101 Q4 | 5 | 0 | 20 | 0 | 2 | 20 | 0.11 | 0.00 | 0.00 | |
203 | Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) Langen | journal | 0.117 Q4 | 10 | 0 | 34 | 0 | 6 | 34 | 0.18 | 0.00 | 0.00 | |
202 | Journal of Clinical and Laboratory Immunology | journal | 0.167 Q4 | 13 | 0 | 10 | 0 | 6 | 10 | 0.00 | 0.00 | 0.00 | |
201 | Advances in Antiviral Drug Design | book series | 0.330 Q4 | 12 | 0 | 7 | 0 | 7 | 5 | 1.00 | 0.00 | 0.00 | |
200 | Annales de l'Institut Pasteur/Actualites | journal | 0.105 Q4 | 10 | 24 | 92 | 848 | 7 | 89 | 0.12 | 35.33 | 40.35 | |
199 | Immunological Medicine | journal | 22 | 25 | 212 | 513 | 7 | 212 | 0.04 | 20.52 | 22.47 | ||
198 | Alpe Adria Microbiology Journal | journal | 0.132 Q4 | 4 | 0 | 43 | 0 | 8 | 34 | 0.56 | 0.00 | 0.00 | |
197 | Clinical and Experimental Allergy Reviews | journal | 0.539 Q3 | 17 | 65 | 4 | 1303 | 9 | 4 | 0.00 | 20.05 | 25.24 | |
196 | Current Issues in Molecular Biology | journal | 0.143 Q4 | 61 | 13 | 28 | 565 | 9 | 28 | 0.32 | 43.46 | 26.32 | |
195 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.102 Q4 | 5 | 8 | 67 | 320 | 13 | 65 | 0.05 | 40.00 | 44.00 | |
194 | International Congress and Symposium Series - Royal Society of Medicine | book series | 0.114 Q4 | 9 | 69 | 265 | 917 | 13 | 261 | 0.04 | 13.29 | 15.56 | |
193 | Current Issues in Intestinal Microbiology | journal | 0.616 Q2 | 39 | 5 | 6 | 544 | 14 | 6 | 2.33 | 108.80 | 33.33 | |
192 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 0.220 Q4 | 5 | 0 | 35 | 0 | 15 | 30 | 0.43 | 0.00 | 0.00 | |
191 | Annals of Microbiology | journal | 0.148 Q4 | 66 | 19 | 46 | 785 | 16 | 46 | 0.36 | 41.32 | 49.02 | |
190 | Current Directions in Autoimmunity | book series | 0.599 Q3 | 38 | 27 | 22 | 3315 | 16 | 22 | 0.73 | 122.78 | 19.70 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®